Evidence map›Paper›PMID 35980608›Full record

ArticleJAMA ophthalmology2022

Association of Predominantly Peripheral Lesions on Ultra-Widefield Imaging and the Risk of Diabetic Retinopathy Worsening Over Time.

Dennis M Marcus, Paolo S Silva, Danni Liu, Lloyd Paul Aiello, Andrew Antoszyk, Michael Elman, Scott Friedman, Adam R Glassman, Joseph M Googe, Lee Merrill Jampol and 6 more

Erratum issuedOpen access · greenAbstract readComment
In one paragraph

Article in JAMA ophthalmology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
12.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 66 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Review
  10. Article
  11. Article
  12. Association of predominant peripheral lesions with retinal microvasculature and risk of vitreous hemorrhage in proliferative diabetic retinopathy.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2025
    Article
  13. Diabetic retinal disease.Nature reviews. Disease primers · 2025
    Review
  14. Article
  15. Article
  16. Posterior Retinal Ischemia Correlates With Vision in Patients With Diabetes.Investigative ophthalmology & visual science · 2025
    Observational
  17. Review
  18. Review
  19. Observational
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 10 institutions in 1 country.

Dennis M MarcusSoutheast Retina Center, Augusta, Georgia.
Paolo S SilvaJoslin Diabetes Center, Beetham Eye Institute, Boston, Massachusetts.
Danni LiuJaeb Center for Health Research, Tampa, Florida.
Lloyd Paul AielloJoslin Diabetes Center, Beetham Eye Institute, Boston, Massachusetts.
Andrew AntoszykCharlotte Eye Ear Nose and Throat Associates, Charlotte, North Carolina.
Michael ElmanElman Retina Group, Baltimore, Maryland.
Scott FriedmanFlorida Retina Consultants, Lakeland.
Adam R GlassmanJaeb Center for Health Research, Tampa, Florida.
Joseph M GoogeSoutheastern Retina Associates, Knoxville, Tennessee.
Lee Merrill JampolFeinberg School of Medicine, Northwestern University, Chicago, Illinois.
Daniel F MartinCole Eye Institute, Cleveland Clinic, Cleveland, Ohio.
Michele MeliaJaeb Center for Health Research, Tampa, Florida.
Carin M PrestonJaeb Center for Health Research, Tampa, Florida.
Charles C WykoffRetina Consultants of Texas, Houston.
Jennifer K SunJoslin Diabetes Center, Beetham Eye Institute, Boston, Massachusetts.
DRCR Retina Network
Jaeb Center for Health Research · USJoslin Diabetes Center · USAugusta University · USCalifornia Retina Consultants · USCharlotte Eye Ear Nose & Throat Associates · USCleveland Clinic · USElman Retina Group · USNorthwestern University · USRetina Consultants of Texas · USSoutheastern Retina Associates · US

Funding

DRCR Retina NetworkUG1EY014231 · NEI · JAEB CENTER FOR HEALTH RESEARCH, INC. · PI Adam R Glassman, DANIEL F MARTIN · 2019 to 2026
$75.4M
SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI JEAN E. SCHAFFER · 1986 to 2026
$50.5M
NEI NIH HHS UG1 EY014231NIDDK NIH HHS P30 DK036836
6 · The paper itself

Abstract

Importance: Ultra-widefield (UWF) imaging improves the ability to identify peripheral diabetic retinopathy (DR) lesions compared with standard imaging. Whether detection of predominantly peripheral lesions (PPLs) better predicts rates of disease worsening over time is unknown. Objective: To determine whether PPLs identified on UWF imaging are associated with increased disease worsening beyond the risk associated with baseline Early Treatment Diabetic Retinopathy Study (ETDRS) Diabetic Retinopathy Severity Scale (DRSS) score. Design, Setting, and Participants: This cohort study was a prospective, multicenter, longitudinal observational study conducted at 37 US and Canadian sites with 388 participants enrolled between February and December 2015. At baseline and annually through 4 years, 200° UWF-color images were obtained and graded for DRSS at a reading center. Baseline UWF-color and UWF-fluorescein angiography (FA) images were evaluated for the presence of PPL. Data were analyzed from May 2020 to June 2022. Interventions: Treatment of DR or diabetic macular edema was at investigator discretion. Main Outcomes and Measures: Predominantly peripheral lesions were defined as DR lesions with a greater extent outside vs inside the 7 standard ETDRS fields. Primary outcome was disease worsening defined as worsening 2 steps or more on the DRSS or receipt of DR treatment. Analyses were adjusted for baseline DRSS score and correlation between 2 study eyes of the same participant. Results: Data for 544 study eyes with nonproliferative DR (NPDR) were analyzed (182 [50%] female participants; median age, 62 years; 68% White). The 4-year disease worsening rates were 45% for eyes with baseline mild NPDR, 40% for moderate NPDR, 26% for moderately severe NPDR, and 43% for severe NPDR. Disease worsening was not associated with color PPL at baseline (present vs absent: 38% vs 43%; HR, 0.78; 95% CI, 0.57-1.08; P = .13) but was associated with FA PPL at baseline (present vs absent: 50% vs 31%; HR, 1.72; 95% CI, 1.25-2.36; P < .001). Conclusions and Relevance: Although no association was identified with color PPL, presence of FA PPL was associated with greater risk of disease worsening over 4 years, independent of baseline DRSS score. These results suggest that use of UWF-FA to evaluate retinas peripheral to standard ETDRS fields may improve the ability to predict disease worsening in NPDR eyes. These findings support use of UWF-FA for future DR staging systems and clinical care to more accurately determine prognosis in NPDR eyes.

Indexed as

Diabetes MellitusDiabetic RetinopathyMacular EdemaCanadaCohort StudiesFemaleFluorescein AngiographyHumansMaleMiddle AgedProspective Studies

Identifiers

PMID35980608
PMCPMC9389433
OpenAlexW4294308723

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.